Results 1 to 10 of about 1,655,298 (265)

Comparison of two high dose rate brachytherapy regimes

open access: yesJournal of Pharmacy and Bioallied Sciences, 2023
Background: Two HDR brachytherapy regimes were compared, 9.5 Gray per fraction for two fractions and 7.5 Gray per fraction for three fractions. Materials and Methods: A total of 80 patients with histologically evident squamous cell carcinoma cervix were ...
Gaurav Jaswal   +4 more
doaj   +3 more sources

Iridium-192 high-dose-rate calibration discrepancies: A growing concern? [PDF]

open access: yesJournal of Contemporary Brachytherapy
Paul Simpson   +4 more
doaj   +2 more sources

High-dose-rate brachytherapy for eyelid carcinoma: Implant technique and review [PDF]

open access: yesJournal of Contemporary Brachytherapy
Eyelid carcinoma is a tumor often detected at an early stage, which can be managed surgically. In non-surgical cases, brachytherapy is a valid alternative or as adjuvant therapy when risk factors exist.
Jose Luis Guinot   +8 more
doaj   +2 more sources

High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials. [PDF]

open access: yesPLoS ONE, 2013
To compare the efficacy and safety of high dose rate (HDR) and low dose rate (LDR) brachytherapy in treating early-stage oral cancer.A systematic search of MEDLINE, EMBASE and Cochrane Library databases, restricted to English language up to June 1, 2012,
Zhenxing Liu   +2 more
doaj   +1 more source

Evaluation of dose–Volume-based image-guided high-dose-rate brachytherapy in carcinoma uterine cervix: A prospective study

open access: yesJournal of Radiation and Cancer Research, 2022
Background: In recent few decades, the evolution in imaging technology, especially computed tomography (CT) and magnetic resonance imaging, results in widespread availability and its use in high-dose-rate (HDR) intracavitary brachytherapy (ICBT ...
Nancy Lal   +7 more
doaj   +1 more source

Dose Optimization in a Fuzzy Model of High-Dose Rate Brachytherapy Problem [PDF]

open access: yesControl and Optimization in Applied Mathematics, 2023
This paper is motivated by high dose rate brachytherapy treatment planning problems which involve the specification of the movement schedule of a radiation source so that the target volumes are adequately covered with sufficient doses and organs at risk ...
Mohammad Mohammadi Najafabadi   +2 more
doaj   +1 more source

An analytic approach to the dosimetry of a new BEBIG 60 Co high-dose-rate brachytherapy source

open access: yesJournal of Medical Physics, 2012
We present a simple analytic tool for calculating the dose rate distribution in water for a new BEBIG high-dose-rate (HDR) 60 Co brachytherapy source. In the analytic tool, we consider the active source as a point located at the geometric center of the ...
Subhalaxmi Bhola   +3 more
doaj   +1 more source

Radioactive Iodine-125 in Tumor Therapy: Advances and Future Directions

open access: yesFrontiers in Oncology, 2021
Radioactive iodine-125 (I-125) is the most widely used radioactive sealed source for interstitial permanent brachytherapy (BT). BT has the exceptional ability to deliver extremely high doses that external beam radiotherapy (EBRT) could never achieve ...
Shuhua Wei   +8 more
doaj   +1 more source

Dosimetry of translational technique for total body irradiation with electrons in Alderson anthropomorphic phantom, for the treatment of mycosis fungoides

open access: yesRevista de Medicina e Investigación Universidad Autónoma del Estado de México, 2021
Total skin electron irradiation (tsei) is one of the most widely used techniques in the treatment of mycosis fungoides (mf). The objective of this work is to carry out the dosimetric characterization of the translational method using a mobile platform at
Steven Rodríguez Cubillos   +6 more
doaj  

High‐dose‐rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report

open access: yesClinical Case Reports, 2019
High‐dose‐rate interstitial brachytherapy (HDR‐ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR‐ISBT.
Yoshiaki Takagawa   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy